Report on von Willebrand Disease in Malaysia

Mercy Halleluyah Periayah; Ahmad Sukari Halim; Arman Zaharil Mat Saad; Nik Soriani Yaacob; Faraizah Abdul Karim

doi:10.3889/oamjms.2016.030

Authors

Mercy Halleluyah Periayah Reconstructive Sciences Unit, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan
Ahmad Sukari Halim Reconstructive Sciences Unit, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan
Arman Zaharil Mat Saad Reconstructive Sciences Unit, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan
Nik Soriani Yaacob Department of Chemical Pathology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan
Faraizah Abdul Karim Hemophilia Clinic, National Blood Centre (Pusat Darah Negara), Jalan Tun Razak, 50400, Wilayah Persekutuan, Kuala Lumpur

DOI:

https://doi.org/10.3889/oamjms.2016.030

Keywords:

von Willebrand Disease, Malaysian report, Sociodemographic details, Laboratory profiles, Year 2011-2013

Abstract

BACKGROUND: Von Willebrand disease (vWD) is an inherited hemostatic disorder that affects the hemostasis pathway. The worldwide prevalence of vWD is estimated to be 1% of the general population but only 0.002% in Malaysia.

AIM: Our present paper has been written to disclose the statistical counts on the number of vWD cases reported from 2011 to 2013.

MATERIAL AND METHODS: This article is based on sociodemographic data, diagnoses and laboratory findings of vWD in Malaysia. A total of 92 patients were reported to have vWD in Malaysia from 2011 to 2013.

RESULTS: Sociodemographic-analysis revealed that 60% were females, 63% were of the Malay ethnicity, 41.3% were in the 19-44 year old age group and 15.2% were from Sabah, with the East region having the highest registered number of vWD cases. In Malaysia, most patients are predominately affected by vWD type 1 (77.2%). Factor 8, von Willebrand factor: Antigen and vWF: Collagen-Binding was the strongest determinants in the laboratory profiles of vWD.

CONCLUSION: This report has been done with great interest to provide an immense contribution from Malaysia, by revealing the statistical counts on vWD from 2011-2013.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Moveforward "Health Care in Malaysia". Expatforum.com. Accessed via: http://en.academic.ru/dic.nsf/enwiki/11562. Accessed on February 25, 2014.

World health ranking website. Accessed via:

http://www.worldlifeexpectancy.com/country-health-profile/malaysia, 2014. Accessed on: March 10, 2014.

Pusat Darah Negara Website, 2012. Accessed via: http://translate.google.com.my/translate?hl=en&sl=ms&u=http://www.pdn.gov.my/&prev=/search%Fq%3Dpusat%2Bdarah%2Bnegara%26biw%3D1024%26bih%3D499. Accessed on March 10, 2014.

Tanushri M. von Willebrand disease: An overview. In book: National Hematology. Chapter: Von Willebrand disease, Publisher: Springer, Editors: Dr MB Agarwal. 2007;131-140.

Goodeve A, Eikenboom J, Castaman G, et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease. (MCMDM-1VWD). Blood. 2007;109:112-121.

http://dx.doi.org/10.1182/blood-2006-05-020784 DOI: https://doi.org/10.1182/blood-2006-05-020784

PMid:16985174

Kwa SB, Chan KY, Chan SK, et al. Haemophilia in Singapore. A study of the clinical and Haematological features in 36 patients. Sing Medic J. 1967;8(1):21-34.

PMid:6044166

Riley RS. von Willebrand Disease. 2005. Accessed via: http://www.pathology.vcu.edu/clinical/coag/vWD.pdf. Accessed on 23th March 2014.

Sadler JE, Budde U, Eikenboom JCJ, et al. Update on the pathophysiology and classification of von Willebrand disease: A report of the subcommittee on von Willebrand factor. J of Thromb & Haemost. 2006;4:2103â€“2114.

http://dx.doi.org/10.1111/j.1538-7836.2006.02146.x DOI: https://doi.org/10.1111/j.1538-7836.2006.02146.x

PMid:16889557

Practical-Hemostasis, A practical guide to laboratory hemostasis. 2012. Accessed via: http://practical-haemostasis.com/Factor%20Assays/VWF/vwf_assays_introduction.html. Accessed on 23th March 2014.

Branchford BR, Di Paola J. Making a diagnosis of VWD. Hematol Am Soc Hematol educ program. 2012;161-167. DOI: https://doi.org/10.1182/asheducation.V2012.1.161.3798231

The Diagnosis, Evaluation, and Management of von willebrand disease. U.S Department of Health and Human Services. National Institutes of Health. National Heart Lung and Blood Institute. NIH Publication No. 08-5832; 2007.

Laffan M, Brown SA, Collins PW, et al. The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors Organization. Haemophilia. 2004;10(3):199-217.

http://dx.doi.org/10.1111/j.1365-2516.2004.00894.x DOI: https://doi.org/10.1111/j.1365-2516.2004.00894.x

PMid:15086318

Keeney S, Bowen D, Cumming A, et al. The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia centre doctors organisation Haemophilia genetics laboratory network. Haemophilia. 2008;14(5):1099-1111.

http://dx.doi.org/10.1111/j.1365-2516.2008.01813.x DOI: https://doi.org/10.1111/j.1365-2516.2008.01813.x

PMid:18637846

Brandt JT. Laboratory Evaluation of Platelet Disorders. In McClatchey, K.D. Clinical Laboratory Medicine, 2nd Ed. Lippincott, Williams, and Wilkins; 2002.

Mohsin S, Aslam M, Hussain S, et al. Clinical manifestations and complications of von Willebrand disease. J Rawalpindi Med College. 2012;6(1):19-21.